Regulated Amino H2O
$10.00
Important research use notice For qualified laboratory research only. Not for human or animal use.
Read notice ↗
Study areas
Product artwork. Refer to the supplied label and batch documentation.
Tesamorelin / Ipamorelin (13/3 MG)
$120.00
Test results & batch recordsView available COAs, results & lot history
Tesamorelin / Ipamorelin combines two catalog-listed peptides with different research targets within growth-hormone signaling.
Bulk orders10–49 or 50+ units
Per product and strength, off the regular price. Automatic savings; discounts cannot be combined.
Complimentary 2-day delivery on bulk orders.
Order multiple products in bulk ↗Delivery & checkoutFree standard shipping on $100+
Complete your lab setupRegulated Amino H2O & insulated packaging
COMPLETE YOUR LAB SETUP
↗
CoolTemp Insulated Bag
$12.00
CONTINUE YOUR RESEARCH
Materials for your next study.
Explore related research materials and lab essentials. Choose a size and add it straight to your bag.
Shop all products ↗↗Lab essentials
CoolTemp Insulated Bag
GH signaling↗Peptide blends
CJC-1295 / Ipamorelin
Metabolic researchReceptor signaling↗Research peptides
GLP-2 TZ
Metabolic researchReceptor signaling↗Research peptides
GLP-3 R
Cellular & redoxMetabolic research↗Research peptides
MOTS-C
Cellular & redoxMetabolic research↗Research peptides
NAD+
DOCUMENTATION, MADE ACCESSIBLE
Verified test results
Review the evidence for Tesamorelin / Ipamorelin (13/3 MG). Published results must be traceable to the original report and the lot on your packaging.
LATEST PUBLISHED RECORD
Batch I/T002
Freedom Diagnostics · Reported August 21, 2026
Purity is reported for the blend, not separately for each ingredient.
Identity
Ipamorelin/TesamorelinMethod: LC-MS
Purity
99.32%Method: HPLC-UV
Net content
Ipamorelin – 3.46 mg; Tesamorelin – 14.50 mgAppearance
White Lyophilized PowderHeavy metals
Not reportedSterility
Not reportedEndotoxin
Not reportedAdditional analysis
Not reportedReport method: HPLC with UV detection coupled with mass spectrometry (LC-MS).
Results are transcribed from the linked certificate after store review. Check the original report and match the lot before relying on a result. “Not reported” does not mean an analysis passed.
A TRACEABLE RESEARCH RECORD
Every batch on record.
The archive for Tesamorelin / Ipamorelin (13/3 MG). Only published, reviewed records are listed; an absent lot has no published documentation here.
I/T002Reported August 21, 2026Latest record +
- Product
- Tesamorelin / Ipamorelin (13/3 MG)
- Laboratory
- Freedom Diagnostics
- Accession
- 2608141127
- Certificate product
- Tesamorelin/Ipamorelin 13mg/3mg
- Identity
- Ipamorelin/TesamorelinMethod: LC-MS
- Purity
- 99.32%Method: HPLC-UV
- Net content
- Ipamorelin – 3.46 mg; Tesamorelin – 14.50 mg
- Appearance
- White Lyophilized Powder
Purity is reported for the blend, not separately for each ingredient.
TECHNICAL SPECS
Compound & formulation information.
Catalog details and published reference information for Tesamorelin / Ipamorelin (13/3 MG). Reference compound properties are separate from the identity, composition, and results of an individual batch.
Catalog specification
- Product
- Tesamorelin / Ipamorelin (13/3 MG)
- Format
- Vial-format material
- Listed package amount
- 13/3 MG
- Product code
- RA-1-13-3-MG
- Documentation
- Reviewed report available above
- Intended use
- Controlled laboratory research
Formulation & handling
Follow the supplied label and supplier documentation for handling and storage. A batch-specific storage temperature, shelf life, salt form, and complete formulation have not been verified here.
- References describe individual components, not studies of this exact blend. Component proportions and analytical identity require the batch report.
GHRH peptide analogue
Tesamorelin
Tesamorelin is a synthetic growth hormone-releasing hormone analogue based on the 44-residue human GHRH sequence. Its literature includes controlled human studies of body composition, liver fat, and endocrine measurements in participants with HIV-associated abdominal fat accumulation. Those investigations concern defined study populations and preparations, with no direct characterization of research-vendor products.
Reference molecular profile
- Residue count
- 44
Reference information does not confirm the salt, variant, composition, or identity supplied in this catalog item.
Synthetic pentapeptide secretagogue
Ipamorelin
Ipamorelin is a synthetic pentapeptide containing nonstandard amino-acid residues and an amidated terminus. It is classified as a growth hormone secretagogue and ghrelin-receptor ligand. Its research literature includes pituitary-cell assays, animal endocrine studies, and human pharmacokinetic modeling that links measured peptide concentrations with growth hormone responses.
Reference molecular profile
- Residue count
- 5
- Reference sequence
- Aib-His-D-2-Nal-D-Phe-Lys-NH2
Reference information does not confirm the salt, variant, composition, or identity supplied in this catalog item.
PEER-REVIEWED LITERATURE
The research, with its sources.
Published compound and ingredient research is provided as scientific context for Tesamorelin / Ipamorelin (13/3 MG). These papers do not verify this supplier’s product, its finished formulation, or any batch. Study findings are specific to the model and conditions described.
- 01
Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension
A randomized trial and extension measured visceral adipose tissue, IGF-I, and other endpoints in participants with HIV-associated abdominal fat accumulation.
Ingredient context: Tesamorelin - 02
Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial
This placebo-controlled study assessed visceral adipose tissue, liver fat, and metabolic measurements in adults with HIV and abdominal fat accumulation.
Ingredient context: Tesamorelin - 03
Ipamorelin, the first selective growth hormone secretagogue
The original pharmacology study characterized ipamorelin in primary rat pituitary cells and in rat and swine endocrine experiments.
Ingredient context: Ipamorelin - 04
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers
A volunteer study modeled the relationship between circulating ipamorelin concentrations and measured growth hormone responses.
Ingredient context: Ipamorelin
IMPORTANT RESEARCH USAGE NOTICE
For research. With responsibility.
Tesamorelin / Ipamorelin (13/3 MG) is offered exclusively for controlled laboratory research by qualified professionals. Not for human or animal use, consumption, or administration.
Products are not intended to diagnose, treat, cure, or prevent disease. Literature is provided for research reference and is not medical advice or evidence validating this product. Purchasers must meet the store’s research eligibility requirements and review the supplied documentation before use.
Read the research use policy ↗DOCUMENTATION, MADE ACCESSIBLE
Verified test results
Review the evidence for Tesamorelin / Ipamorelin (13/3 MG) — select mass. Published results must be traceable to the original report and the lot on your packaging.
No verified batch results are published yet.
Tesamorelin / Ipamorelin (13/3 MG) — select mass documentation will appear here after the actual report is uploaded and reviewed. No purity, identity, or pass/fail result is implied.
Request a batch COA →Identity
Not reportedAwaiting the original batch certificate.
Purity
Not reportedAwaiting the original batch certificate.
Net content
Not reportedAwaiting the original batch certificate.
Microbiological results
Not reportedAwaiting the original batch certificate.
A TRACEABLE RESEARCH RECORD
Every batch on record.
The archive for Tesamorelin / Ipamorelin (13/3 MG) — select mass. Only published, reviewed records are listed; an absent lot has no published documentation here.
No batch records have been published for this product yet.
Ask about your batch ↗